Novartis Presents New Clinical Trial ALS Digital Health Biomarkers
At Panagora’s 7th Annual Digital Biomarkers in Clinical Trials Summit, Novartis presented a groundbreaking study on digital home-based assessments...
AI in Biopharmaceutical R&D: From Theory to Practice
At a recent conference, industry leaders gathered to explore the transformative potential of artificial intelligence (AI) in clinical trials,...
How High Interest Rates Are Impacting Clinical Trial Investment
The DPHARM 2024 conference recently convened a panel of industry leaders to discuss the alignment of innovations to address...
DPHARM Follow the Money: Investor Insights on Technology Investment in Clinical Trials
The DPHARM conference brought together a distinguished panel to discuss the critical role of technology investment in clinical trials....
How Johnson & Johnson is Innovating its Organizational Infrastructure
At DPHARM 2024, Johnson & Johnson’s representatives, Gordon Gregory III, and Laszlo Vasko, unveiled their transformative “Team of Teams”...
Walgreens and AstraZeneca: Pioneering Accessible Clinical Trials
In a groundbreaking collaboration, Walgreens, AstraZeneca, and digital health company Evinova revealed at DPHARM 2024 that they have embarked on a...
How To Measure ROI in Decentralized Clinical Trials
At the 2024 DPHARM conference, Ken Getz, Executive Director and Research Professor at Tufts Center for the Study of...
Navigating Clinical Research Technology As a Study Site
In this interview, we sit down with Alisha Garibaldi, CEO of Skylight Health Research, to discuss managing clinical research...
How AI is Transforming RBQM in Clinical Trials
A recent virtual summit hosted by Cyntegrity focused on the pivotal role of artificial intelligence (AI) in Risk-Based Quality...
Johnson & Johnson’s Innovative Approach to Enhancing Diversity in Clinical Trials
At DPHARM 2024, Johnson & Johnson (J&J) unveiled their groundbreaking strategies to improve diversity, equity, and inclusion (DE&I) in...